Articles published by Genmab A/S
![](https://mms.businesswire.com/media/20240819250512/en/2219240/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20240816647609/en/2217611/5/Genmab_Logo_Color_RGB.jpg)
Genmab Announces Changes to its Executive Committee
August 16, 2024
From Genmab A/S
Via Business Wire
Tickers
GMAB
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Genmab Announces Financial Results for the First Half of 2024
August 08, 2024
From Genmab A/S
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Genmab Takes Full Control of Acasunlimab Development Program
August 05, 2024
From Genmab A/S
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240627569754/en/2172406/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20240626204925/en/2171499/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20240603640244/en/2146969/22/GenmabLogo.jpg)
![](https://mms.businesswire.com/media/20240602990089/en/2147628/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20240523620002/en/2138830/22/GenmabLogo.jpg)
![](https://mms.businesswire.com/media/20240521989095/en/2137492/5/Genmab_Logo_Color_RGB.jpg)
Genmab Completes Acquisition of ProfoundBio
May 21, 2024
From Genmab A/S
Via Business Wire
Tickers
GMAB
![](https://mms.businesswire.com/media/20240601902871/en/2147002/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20240514430927/en/2129709/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
From Genmab A/S
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240422914519/en/2105097/22/GenmabLogo.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20240402203285/en/2087648/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20240227092202/en/2045857/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Genmab Announces Initiation of Share Buy-Back Program
February 14, 2024
From Genmab A/S
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20240202549142/en/2018874/22/GenmabLogo.jpg)
![](https://mms.businesswire.com/media/20240105049976/en/1989817/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20231208348497/en/1964677/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20231126633910/en/1952547/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.